Time for a Clinical Trials Revolution – Complex Innovative Design (CID) Cancer Trials
This 1-hour webinar reviews a published consensus statement from the British Journal of Cancer (BJC), looking at recommendations for effective…
Webinars
Discover the latest in clinical development, trials and data management, from our in-house experts, available on demand now.
Meeting the Needs of Rare Disease Patients in Clinical Trials During the COVID-19 Pandemic
A Discussion on Regulatory and Operational Considerations This 1-hour webinar discusses how the COVID-19 pandemic has impacted clinical studies for rare diseases and how patient-centric trial design with regulatory consideration can be utilised to mitigate and manage potential delays and support patient recruitment in rare and orphan clinical trials. About…
Phase I Studies in Patient Populations:De-risking Clinical Development by Obtaining Key Patient Data Earlier
In this webinar members of our specialist, early phase Project Management team discuss how they tackled the range of challenges…
Rare Disease & Orphan Drug Development - Cost-efficient trial design to minimise cash burn
Discussion topics include: Key challenges to improve cost-efficiency in clinical development of orphan drugs Regulatory evolution in the review process…
Effective Implementation of the Revised EMA First-into-Human (FiH) Guidance to Accelerate Your Early Clinical Development
In this webinar the speakers discuss the use of integrated protocols (umbrella protocols) to maximise programme efficiency. Attendees will learn how…
Scintigraphy: Providing Critical Data in Early Clinical Development
If you are embarking on your clinical development plan, consider a non-invasive in vivo evaluation of drug delivery systems. Scintigraphy gives you the…
Conducting Early Phase Oncology Studies - Successfully moving through to proof of concept and beyond
This one-hour webinar focuses on strategic considerations for the molecule, including a brief review of the dynamic research landscape of oncology…
Agility In Rare Diseases & Oncology Clinical Trials - Data Management
Modular and adaptive clinical trials are rapidly expanding the ability of researchers to modify clinical trials based on emerging data, i.e. to…
Achieving Orphan Designation (ODD) - Meeting the unmet need
Achieving Orphan Drug Designation is a significant step enabling your product to be licensed faster, in a cost-efficient manner, and achieve market exclusivity…
ESMO Update: State of the Art in Early Phase Oncology Trial Design
The science looks promising and you have secured vital funding to take your compound to the clinical stage. What is…